Progression in MCF-7 breast cancer cell tumorigenicity: Compared effect of FGF-3 and FGF-4

Breast Cancer Research and Treatment

Volumn 60, Issue 1, 2000, Pages 15-28

  Hajitou, Amin ^a   Deroanne, Christophe ^a   Noël, Agnès ^b   Collette, Julien ^a   Nusgens, Betty ^a   Foidart, Jean Michel ^b   Calberg Bacq, Claire M ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

FGF 3; FGF 4; MCF 7 breast cancer cells; Tumorigenicity; VEGF

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; MATRIGEL; MESSENGER RNA; VASCULOTROPIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOGENICITY; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA TRANSLATION; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CADHERINS; CARCINOGENICITY TESTS; CELL DIVISION; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTORS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOKINES; MICE; MICE, NUDE; PROTO-ONCOGENE PROTEINS; RECEPTORS, ESTRADIOL; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034107392     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006302602261     Document Type: Article

References (56)

1. 1. Koga C, Adati N, Nakata K, Mikoshiba K, Furuhata Y, Sato S, Tei H, Sakaki Y, Kurokawa T, Shiokawa K, Yokoyama KK: Characterization of a novel member of the FGF family, XFGF-20, in Xenopus laevis. Biochem Biophys Res Commun 261: 756-765, 1999
2. 2. Basilico C, Moscalelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-116, 1992
3. 3. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K: Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of the mouse mammary carcinoma cells. Proc Natl Acad Sci USA 89: 8928-8932, 1992
4. 4. Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T, Kurokawa T: Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13: 4251-4259, 1993
5. 5. Emoto H, Tagashira S, Mattei MG, Yamasaki M, Hashimoto G, Katsumata T, Negoros T, Nakatsuka M, Birnbaum D, Coulier F, Itoh N: Structure and expression of human fibroblast growth factor-10. J Biol Chem 272: 23191-23194, 1997
6. 6. Goldfarb M: Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7: 311-325, 1996
7. 7. Dickson C, Smith R, Brookes S, Peters G: Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 37: 529-536, 1984
8. 8. Peters G, Brookes S, Smith R, Placzek M, Dickson C: The mouse homolog of the hst/k/FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci USA 86: 5678-5682, 1989
9. 9. Clausse N, Smith R, Calberg-Bacq CM, Peters G, Dickson C: Mouse mammary tumor virus activates Fgf-3/int-2 less frequently in tumors from virgin than from parous mice. Int J Cancer 55: 157-163, 1993
10. 10. Murakami A, Tanaka H, Matsuzawa A: Association of the hst gene expression with metastatic phenotype in mouse mammary tumors. Cell Growth Diff 1: 1-5, 1990
11. 11. Kapoun AM, Shackleford GM: Preferential activation of Fgf-8 by proviral insertion in mammary tumors of Wnt-1 transgenic mice. Oncogene 14: 2985-2989, 1997
12. 12. Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P, Leder P: The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 9: 907-913, 1990
13. 13. Kitsberg D, Leder P: Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 13: 2507-2515, 1996
14. 14. Penault-Llorca F, Bertucci F, Adelaide J, Parc P, Coulier F, Jacquemier J, Birnbaum D, de Lapeyriere O: Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61: 170-176, 1995
15. 15. Penault-Llorca F, Bertucci F, Sun ZZ, Viens P, Coulier F, Jacquemier J, Birnbaum D: Expression of FGF and FGF receptor genes in breast carcinomas. In: 21st meeting of the International Association for Breast Cancer Research. Paris (France), July 3-5, 1996, Abstract 11, p 34
16. 16. Bansal GS, Yiangou C, Coope RC, Gomm GG, Luqmani YA, Coombes RC, Johnston CL: Expression of fibroblast growth factor 1 is lower in breast cancer than in normal human breast. Br J Cancer 72: 1420-1426, 1995
17. 17. Yiangou C, Gomm JJ, Coope RC, Law M, Luqmani YA, Shousha S, Coombes RC, Johnston, CL: Fibroblast growth factor 2 in breast cancer: occurence and prognostic significance. Br J Cancer 75: 28-33, 1997
18. 18. Bansal GS, Cox HS, Marsh S, Gomm JJ, Yiangou C, Luqmani Y, Coombes RC, Johnston CL: Expression of keratinocyte growth factor and its receptor in human breast cancer. Br J Cancer 75: 1567-1574, 1997
19. 19. Russo J, Barnabas N, Higgy N, Salicioni AM, Wu YL, Russo IH: Molecular basis of human breast epithelial cell transformation. In: Calvo F, Crépin M, Magdalenat H (eds) Breast Cancer Advances in Biology & Therapeutics. John Libbey, Eurotext, Montrouge, 1996, pp 33-43
20. 20. Zhang PL, Chai YL, Ho TY, Calaf G, Russo J: Activation of c-myc, c-neu and int-2 oncogenes in the transformation of the human breast epithelial cell line in MCF-10F treated with chemical carcinogens in vitro. Int J Oncol 6: 963-968, 1995
21. 21. Hajitou A, Calberg-Bacq CM: Fibroblast growth factor-3 is tumorigenic for mouse mammary cells orthotopically implanted in nude mice. Int J Cancer 63: 702-709, 1995
22. 22. Hajitou A, Baramova EN, Bajou K, Noë V, Bruyneel E, Marcel M, Collette J, Foidart J-M, Calberg-Bacq C-M: FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells. Oncogene 16: 2059-2071, 1998
23. 23. Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1415, 1973
24. 24. Kern FG, McLeskey SW, Zhang L, Kurebayashi J, Liu Y, Ding IYF, Kharbanda S, Chen D, Miller D, Cullen K, Paik S, Dickson RB: Transfected MCF7 cells as a model for breast cancer progression. Breast Cancer Res Treat 31: 153-165, 1994
25. 25. McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis. Breast Cancer Res Treat 39: 103-117, 1996
26. 26. Lehtola L, Partanen J, Sistonen L, Korhonen J, Warri A, Harkonen P, Clarke R, Alitalo K: Analysis of tyrosine kinase mRNAs expressed in MCF7 breast cancer cells. Int J Cancer 50: 598-603, 1992
27. 27. Zhang L, Kharbanda S, Chen D, Bullocks J, Miller DL, Ding IYF, Hantelt J, McLeskey SW, Kern FG: MCF7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Oncogene 15: 2093-2108, 1997
28. 28. Zhang L, Kharbanda S, Hanfelt J, Kern FG: Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF7 breast cancer cells. Cancer Res 58: 352-361, 1998
29. 29. Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalon J: Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin Cancer Res 3: 135-142, 1997
30. 1 events. Cancer Res 57: 1750-1757, 1997
31. 31. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor-4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 53: 2168-2177, 1993
32. 32. Kurebayashi D, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG: Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 53: 2178-2187, 1993
33. 33. Markowitz D, Stephen G, Bank A: Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167: 400-406, 1988
34. 34. Acland P, Dixon M, Peters G, Dickson C: Subcellular fate of the int-2 oncoprotein is determined by choice of initiation codon. Nature (Lond) 343: 662-665, 1990
35. 35. Deroanne CF, Hajitou A, Calberg-Bacq CM, Nusgens BV, Lapiere CM: Angiogenesis by fibroblast growth factor-4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res 57: 5590-5597, 1997
36. 36. Noel A, Simon N, Raus J, Foidart JM: Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol 43: 1263-1267, 1992
37. 37. Gilles C, Thompson EW: The epithelial to mesenchymal transition and metastatic progression in carcinoma. The Breast J 2: 83-96, 1996
38. 38. Butler WB, Berlinski PJ, Hillman RM, Kelsey WH, Toenniges MM: Relation of in vitro properties to tumorigenicity for a series of sublines of the human breast cancer cell line MCF-7. Cancer Res 46: 6339-6348, 1986
39. 39. Basolo F, Venesio T, Calvo S, Fiore L, Fontanini G, Ciardiello F, Toniolo A, Liscia D, Merlo GR: The effects of fgf-3/int-2 on growth and transformation of MCF-10A normal human mammary epithelial cells is distinct from Fgf-1 and Fgf-2. Int J Oncol 4: 1365-1370, 1993
40. 40. Costa M, Danesi R, Agen C, Di Paolo A, Basolo F, Bianchi SD, Tacca MD: MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery. Cancer Res 54: 9-11, 1994
41. 41. Venesio T, Taverna D, Hynes NE, Deed R, Macallan D, Ciardiello F, Valverius EM, Salomon DS, Callahan DR, Merlo G: The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line. Cell Growth Diff 3: 63-71, 1992
42. 42. Merlo GR, Blondel BJ, Deed R, Macallan D, Peters G, Dickson C, Liscia DS, Ciardiello F, Valverius EM, Salmon DS, Callahan R: The mouse int-2 gene exhibits basic fibroblast growth activity in a basic growth factor-responsive cell line. Cell Growth Diff 1: 463-472, 1990
43. 43. Talarico D, Basilico C: The kFGF/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway. Mol Cell Biol 11: 1138-1145, 1991
44. 44. Kiefer P, Peters G, Dickson C: The int-2/Fgf-3 oncogene product is secreted and associates with extracellular matrix: implications for cell transformation. Mol Cell Biol 11: 5929-5936, 1991
45. 45. Takei Y, Higashira H, Yamamoto T, Hayashi K: Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: cooperarive role of cathepsin D. Breast Cancer Res Treat 43: 53-63, 1997
46. 46. Tang CK, Perez C, Grunt T, Waibel C, Cho C, Ruth L: Involvement of heregulin-β2 in the acquisition of the hormone-independent phenotype of breast cancer cells. Cancer Res 56: 3350-3358, 1996
47. 47. McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG: Tamoxifen-resistant fibroblast growth factor-transfected MCF7 cells are cross-resistant in vivo to the anti-estrogen ICI 182, 780 and two aromatase inhibitors. Clin Cancer Res 4: 697-711, 1998
48. 48. Noel A, De Pauw-Gillet MC, Purnel LG, Nusgens B, Lapiere CM, Foidart JM: Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br J Cancer 68: 909-915, 1993
49. 49. McLeskey SW, Ding IYF, Lippman ME, Kern FG: MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor receptors and are growth inhibited by FGF ligands. Cancer Res 54: 523-530, 1994
50. 50. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L: The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368: 237-239, 1994
51. 51. Klauber N, Parangi S, Flynn E, Hamel B, D'Amato DJ: Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57: 81-86, 1997
52. 52. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990
53. 53. Jouanneau J, Moens G, Montesano R, Thiery JP: FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation. Growth Factors 12: 37-17, 1995
54. 54. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Philips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumor growth in vivo. Nature 362: 841-844, 1993
55. 55. Relf M, Lejeune S, Scott PAE, Fox S, Smith K, Leek R, Moghaddam A, White House R, Bicknell R, Harris L: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57: 963-969, 1997
56. 56. McLeskey SW, Tobias CA, Vezza PR, Filie AC, Kern FG, Hanfelt J: Tumor growth of FGF or VEGF transfectcd MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor. Am J Pathol 153: 1993-2006, 1998